nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—Erlotinib—pancreatic cancer	0.259	0.361	CbGbCtD
Cefotetan—ALB—Irinotecan—pancreatic cancer	0.234	0.326	CbGbCtD
Cefotetan—ALB—Fluorouracil—pancreatic cancer	0.224	0.313	CbGbCtD
Cefotetan—Superinfection—Fluorouracil—pancreatic cancer	0.0116	0.0408	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Tamoxifen—pancreatic cancer	0.0074	0.0261	CcSEcCtD
Cefotetan—Cholestasis—Tamoxifen—pancreatic cancer	0.00512	0.0181	CcSEcCtD
Cefotetan—Nephropathy toxic—Gemcitabine—pancreatic cancer	0.00466	0.0164	CcSEcCtD
Cefotetan—Thrombocytosis—Gemcitabine—pancreatic cancer	0.0043	0.0152	CcSEcCtD
Cefotetan—Blood bilirubin increased—Tamoxifen—pancreatic cancer	0.00411	0.0145	CcSEcCtD
Cefotetan—Vaginal inflammation—Tamoxifen—pancreatic cancer	0.00389	0.0137	CcSEcCtD
Cefotetan—Colitis—Erlotinib—pancreatic cancer	0.0037	0.013	CcSEcCtD
Cefotetan—Vaginal infection—Tamoxifen—pancreatic cancer	0.00367	0.013	CcSEcCtD
Cefotetan—Blood bilirubin increased—Sunitinib—pancreatic cancer	0.00352	0.0124	CcSEcCtD
Cefotetan—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.00323	0.0114	CcSEcCtD
Cefotetan—Prothrombin level increased—Epirubicin—pancreatic cancer	0.00312	0.011	CcSEcCtD
Cefotetan—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.0031	0.0109	CcSEcCtD
Cefotetan—Blood bilirubin increased—Irinotecan—pancreatic cancer	0.0029	0.0102	CcSEcCtD
Cefotetan—Prothrombin level increased—Doxorubicin—pancreatic cancer	0.00289	0.0102	CcSEcCtD
Cefotetan—Blood bilirubin increased—Gemcitabine—pancreatic cancer	0.00283	0.00997	CcSEcCtD
Cefotetan—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.00277	0.00976	CcSEcCtD
Cefotetan—Colitis—Irinotecan—pancreatic cancer	0.00264	0.00929	CcSEcCtD
Cefotetan—Vaginal moniliasis—Epirubicin—pancreatic cancer	0.00254	0.00894	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00252	0.00887	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Epirubicin—pancreatic cancer	0.00243	0.00858	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—pancreatic cancer	0.00235	0.00827	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Epirubicin—pancreatic cancer	0.00234	0.00825	CcSEcCtD
Cefotetan—Pancytopenia—Tamoxifen—pancreatic cancer	0.00232	0.00817	CcSEcCtD
Cefotetan—Neutropenia—Tamoxifen—pancreatic cancer	0.00228	0.00805	CcSEcCtD
Cefotetan—Neutropenia—Erlotinib—pancreatic cancer	0.00226	0.00796	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—pancreatic cancer	0.00225	0.00794	CcSEcCtD
Cefotetan—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.00222	0.00783	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00218	0.00768	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—pancreatic cancer	0.00217	0.00764	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00216	0.00761	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00213	0.00753	CcSEcCtD
Cefotetan—Thrombocytosis—Epirubicin—pancreatic cancer	0.00206	0.00726	CcSEcCtD
Cefotetan—Blood bilirubin increased—Docetaxel—pancreatic cancer	0.00201	0.00707	CcSEcCtD
Cefotetan—Pancytopenia—Sunitinib—pancreatic cancer	0.00199	0.007	CcSEcCtD
Cefotetan—Haemoglobin—Tamoxifen—pancreatic cancer	0.00196	0.00692	CcSEcCtD
Cefotetan—Neutropenia—Sunitinib—pancreatic cancer	0.00196	0.00689	CcSEcCtD
Cefotetan—Haemorrhage—Tamoxifen—pancreatic cancer	0.00195	0.00689	CcSEcCtD
Cefotetan—Haemoglobin—Erlotinib—pancreatic cancer	0.00194	0.00685	CcSEcCtD
Cefotetan—Haemorrhage—Erlotinib—pancreatic cancer	0.00193	0.00682	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—pancreatic cancer	0.0019	0.00672	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00185	0.00652	CcSEcCtD
Cefotetan—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00185	0.00651	CcSEcCtD
Cefotetan—Erythema multiforme—Erlotinib—pancreatic cancer	0.00183	0.00645	CcSEcCtD
Cefotetan—Colitis—Docetaxel—pancreatic cancer	0.00182	0.00642	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00175	0.00616	CcSEcCtD
Cefotetan—Haemoglobin—Sunitinib—pancreatic cancer	0.00168	0.00593	CcSEcCtD
Cefotetan—Haemorrhage—Sunitinib—pancreatic cancer	0.00167	0.0059	CcSEcCtD
Cefotetan—Eosinophilia—Fluorouracil—pancreatic cancer	0.00163	0.00576	CcSEcCtD
Cefotetan—Neutropenia—Irinotecan—pancreatic cancer	0.00161	0.00568	CcSEcCtD
Cefotetan—Phlebitis—Docetaxel—pancreatic cancer	0.0016	0.00564	CcSEcCtD
Cefotetan—Pancytopenia—Gemcitabine—pancreatic cancer	0.00159	0.00562	CcSEcCtD
Cefotetan—Erythema multiforme—Sunitinib—pancreatic cancer	0.00158	0.00558	CcSEcCtD
Cefotetan—Neutropenia—Gemcitabine—pancreatic cancer	0.00157	0.00553	CcSEcCtD
Cefotetan—Pancytopenia—Fluorouracil—pancreatic cancer	0.00157	0.00552	CcSEcCtD
Cefotetan—Leukopenia—Tamoxifen—pancreatic cancer	0.00152	0.00537	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00148	0.00523	CcSEcCtD
Cefotetan—Discomfort—Tamoxifen—pancreatic cancer	0.00143	0.00504	CcSEcCtD
Cefotetan—Agranulocytosis—Gemcitabine—pancreatic cancer	0.0014	0.00492	CcSEcCtD
Cefotetan—Haemoglobin—Irinotecan—pancreatic cancer	0.00139	0.00489	CcSEcCtD
Cefotetan—Haemorrhage—Irinotecan—pancreatic cancer	0.00138	0.00486	CcSEcCtD
Cefotetan—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00137	0.00484	CcSEcCtD
Cefotetan—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00136	0.00479	CcSEcCtD
Cefotetan—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.00135	0.00477	CcSEcCtD
Cefotetan—Haemoglobin—Gemcitabine—pancreatic cancer	0.00135	0.00476	CcSEcCtD
Cefotetan—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00134	0.00474	CcSEcCtD
Cefotetan—Haemorrhage—Gemcitabine—pancreatic cancer	0.00134	0.00473	CcSEcCtD
Cefotetan—Haemoglobin—Fluorouracil—pancreatic cancer	0.00133	0.00468	CcSEcCtD
Cefotetan—Haemorrhage—Fluorouracil—pancreatic cancer	0.00132	0.00466	CcSEcCtD
Cefotetan—Leukopenia—Sunitinib—pancreatic cancer	0.0013	0.0046	CcSEcCtD
Cefotetan—Vaginal inflammation—Epirubicin—pancreatic cancer	0.00128	0.00451	CcSEcCtD
Cefotetan—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00127	0.00448	CcSEcCtD
Cefotetan—Convulsion—Sunitinib—pancreatic cancer	0.00126	0.00445	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.00125	0.00441	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00124	0.00437	CcSEcCtD
Cefotetan—Colitis—Epirubicin—pancreatic cancer	0.00123	0.00433	CcSEcCtD
Cefotetan—Vaginal infection—Epirubicin—pancreatic cancer	0.00121	0.00426	CcSEcCtD
Cefotetan—Aplastic anaemia—Epirubicin—pancreatic cancer	0.0012	0.00424	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00118	0.00418	CcSEcCtD
Cefotetan—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00116	0.0041	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—pancreatic cancer	0.00114	0.00401	CcSEcCtD
Cefotetan—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00114	0.004	CcSEcCtD
Cefotetan—Pancytopenia—Docetaxel—pancreatic cancer	0.00113	0.00399	CcSEcCtD
Cefotetan—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00112	0.00396	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—pancreatic cancer	0.00112	0.00394	CcSEcCtD
Cefotetan—Neutropenia—Docetaxel—pancreatic cancer	0.00111	0.00393	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00111	0.00392	CcSEcCtD
Cefotetan—Urticaria—Tamoxifen—pancreatic cancer	0.0011	0.00389	CcSEcCtD
Cefotetan—Abdominal pain—Tamoxifen—pancreatic cancer	0.0011	0.00387	CcSEcCtD
Cefotetan—Abdominal pain—Erlotinib—pancreatic cancer	0.00109	0.00383	CcSEcCtD
Cefotetan—Body temperature increased—Erlotinib—pancreatic cancer	0.00109	0.00383	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—pancreatic cancer	0.00108	0.0038	CcSEcCtD
Cefotetan—Leukopenia—Irinotecan—pancreatic cancer	0.00107	0.00379	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00106	0.00375	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00105	0.00371	CcSEcCtD
Cefotetan—Leukopenia—Gemcitabine—pancreatic cancer	0.00105	0.00369	CcSEcCtD
Cefotetan—Leukopenia—Fluorouracil—pancreatic cancer	0.00103	0.00363	CcSEcCtD
Cefotetan—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00102	0.00361	CcSEcCtD
Cefotetan—Discomfort—Irinotecan—pancreatic cancer	0.00101	0.00356	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—pancreatic cancer	0.000998	0.00352	CcSEcCtD
Cefotetan—Convulsion—Fluorouracil—pancreatic cancer	0.000996	0.00351	CcSEcCtD
Cefotetan—Agranulocytosis—Docetaxel—pancreatic cancer	0.000991	0.00349	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000984	0.00347	CcSEcCtD
Cefotetan—Discomfort—Gemcitabine—pancreatic cancer	0.000983	0.00347	CcSEcCtD
Cefotetan—Pruritus—Tamoxifen—pancreatic cancer	0.000982	0.00346	CcSEcCtD
Cefotetan—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000979	0.00345	CcSEcCtD
Cefotetan—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000972	0.00343	CcSEcCtD
Cefotetan—Pruritus—Erlotinib—pancreatic cancer	0.000972	0.00343	CcSEcCtD
Cefotetan—Discomfort—Fluorouracil—pancreatic cancer	0.000967	0.00341	CcSEcCtD
Cefotetan—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000959	0.00338	CcSEcCtD
Cefotetan—Haemoglobin—Docetaxel—pancreatic cancer	0.000958	0.00338	CcSEcCtD
Cefotetan—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000954	0.00336	CcSEcCtD
Cefotetan—Haemorrhage—Docetaxel—pancreatic cancer	0.000953	0.00336	CcSEcCtD
Cefotetan—Diarrhoea—Tamoxifen—pancreatic cancer	0.00095	0.00335	CcSEcCtD
Cefotetan—Abdominal pain—Sunitinib—pancreatic cancer	0.00094	0.00331	CcSEcCtD
Cefotetan—Body temperature increased—Sunitinib—pancreatic cancer	0.00094	0.00331	CcSEcCtD
Cefotetan—Diarrhoea—Erlotinib—pancreatic cancer	0.00094	0.00331	CcSEcCtD
Cefotetan—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000938	0.00331	CcSEcCtD
Cefotetan—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000934	0.00329	CcSEcCtD
Cefotetan—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000918	0.00324	CcSEcCtD
Cefotetan—Erythema multiforme—Docetaxel—pancreatic cancer	0.000901	0.00318	CcSEcCtD
Cefotetan—Vomiting—Tamoxifen—pancreatic cancer	0.000883	0.00311	CcSEcCtD
Cefotetan—Hypersensitivity—Sunitinib—pancreatic cancer	0.000876	0.00309	CcSEcCtD
Cefotetan—Rash—Tamoxifen—pancreatic cancer	0.000875	0.00309	CcSEcCtD
Cefotetan—Dermatitis—Tamoxifen—pancreatic cancer	0.000874	0.00308	CcSEcCtD
Cefotetan—Vomiting—Erlotinib—pancreatic cancer	0.000873	0.00308	CcSEcCtD
Cefotetan—Rash—Erlotinib—pancreatic cancer	0.000866	0.00305	CcSEcCtD
Cefotetan—Dermatitis—Erlotinib—pancreatic cancer	0.000865	0.00305	CcSEcCtD
Cefotetan—Pruritus—Sunitinib—pancreatic cancer	0.000841	0.00297	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000837	0.00295	CcSEcCtD
Cefotetan—Nausea—Tamoxifen—pancreatic cancer	0.000825	0.00291	CcSEcCtD
Cefotetan—Nausea—Erlotinib—pancreatic cancer	0.000816	0.00288	CcSEcCtD
Cefotetan—Diarrhoea—Sunitinib—pancreatic cancer	0.000813	0.00287	CcSEcCtD
Cefotetan—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000801	0.00282	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—pancreatic cancer	0.000795	0.0028	CcSEcCtD
Cefotetan—Abdominal pain—Irinotecan—pancreatic cancer	0.000774	0.00273	CcSEcCtD
Cefotetan—Body temperature increased—Irinotecan—pancreatic cancer	0.000774	0.00273	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000774	0.00273	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—pancreatic cancer	0.000763	0.00269	CcSEcCtD
Cefotetan—Vomiting—Sunitinib—pancreatic cancer	0.000756	0.00267	CcSEcCtD
Cefotetan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000754	0.00266	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—pancreatic cancer	0.000751	0.00265	CcSEcCtD
Cefotetan—Rash—Sunitinib—pancreatic cancer	0.00075	0.00264	CcSEcCtD
Cefotetan—Dermatitis—Sunitinib—pancreatic cancer	0.000749	0.00264	CcSEcCtD
Cefotetan—Urticaria—Fluorouracil—pancreatic cancer	0.000745	0.00263	CcSEcCtD
Cefotetan—Leukopenia—Docetaxel—pancreatic cancer	0.000743	0.00262	CcSEcCtD
Cefotetan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000741	0.00261	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—pancreatic cancer	0.000736	0.00259	CcSEcCtD
Cefotetan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000722	0.00254	CcSEcCtD
Cefotetan—Convulsion—Docetaxel—pancreatic cancer	0.000719	0.00253	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00071	0.0025	CcSEcCtD
Cefotetan—Nausea—Sunitinib—pancreatic cancer	0.000706	0.00249	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—pancreatic cancer	0.000706	0.00249	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—pancreatic cancer	0.000695	0.00245	CcSEcCtD
Cefotetan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000691	0.00244	CcSEcCtD
Cefotetan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000677	0.00239	CcSEcCtD
Cefotetan—Pruritus—Gemcitabine—pancreatic cancer	0.000675	0.00238	CcSEcCtD
Cefotetan—Diarrhoea—Irinotecan—pancreatic cancer	0.00067	0.00236	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—pancreatic cancer	0.000668	0.00236	CcSEcCtD
Cefotetan—Pruritus—Fluorouracil—pancreatic cancer	0.000664	0.00234	CcSEcCtD
Cefotetan—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000663	0.00234	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000657	0.00232	CcSEcCtD
Cefotetan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000653	0.0023	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—pancreatic cancer	0.000646	0.00228	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—pancreatic cancer	0.000643	0.00227	CcSEcCtD
Cefotetan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000642	0.00226	CcSEcCtD
Cefotetan—Vomiting—Irinotecan—pancreatic cancer	0.000623	0.0022	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000618	0.00218	CcSEcCtD
Cefotetan—Rash—Irinotecan—pancreatic cancer	0.000617	0.00218	CcSEcCtD
Cefotetan—Dermatitis—Irinotecan—pancreatic cancer	0.000617	0.00218	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—pancreatic cancer	0.000608	0.00214	CcSEcCtD
Cefotetan—Vomiting—Gemcitabine—pancreatic cancer	0.000607	0.00214	CcSEcCtD
Cefotetan—Rash—Gemcitabine—pancreatic cancer	0.000601	0.00212	CcSEcCtD
Cefotetan—Dermatitis—Gemcitabine—pancreatic cancer	0.000601	0.00212	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—pancreatic cancer	0.000598	0.00211	CcSEcCtD
Cefotetan—Vomiting—Fluorouracil—pancreatic cancer	0.000596	0.0021	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—pancreatic cancer	0.000595	0.0021	CcSEcCtD
Cefotetan—Rash—Fluorouracil—pancreatic cancer	0.000591	0.00209	CcSEcCtD
Cefotetan—Dermatitis—Fluorouracil—pancreatic cancer	0.000591	0.00208	CcSEcCtD
Cefotetan—Nausea—Irinotecan—pancreatic cancer	0.000582	0.00205	CcSEcCtD
Cefotetan—Nausea—Gemcitabine—pancreatic cancer	0.000567	0.002	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000562	0.00198	CcSEcCtD
Cefotetan—Nausea—Fluorouracil—pancreatic cancer	0.000557	0.00196	CcSEcCtD
Cefotetan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000554	0.00195	CcSEcCtD
Cefotetan—Abdominal pain—Docetaxel—pancreatic cancer	0.000535	0.00189	CcSEcCtD
Cefotetan—Body temperature increased—Docetaxel—pancreatic cancer	0.000535	0.00189	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—pancreatic cancer	0.000501	0.00177	CcSEcCtD
Cefotetan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000499	0.00176	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—pancreatic cancer	0.000485	0.00171	CcSEcCtD
Cefotetan—Pruritus—Docetaxel—pancreatic cancer	0.000479	0.00169	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—pancreatic cancer	0.000471	0.00166	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—pancreatic cancer	0.000463	0.00163	CcSEcCtD
Cefotetan—Diarrhoea—Docetaxel—pancreatic cancer	0.000463	0.00163	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000457	0.00161	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—pancreatic cancer	0.000449	0.00158	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000447	0.00158	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—pancreatic cancer	0.000435	0.00154	CcSEcCtD
Cefotetan—Vomiting—Docetaxel—pancreatic cancer	0.00043	0.00152	CcSEcCtD
Cefotetan—Rash—Docetaxel—pancreatic cancer	0.000427	0.00151	CcSEcCtD
Cefotetan—Dermatitis—Docetaxel—pancreatic cancer	0.000426	0.0015	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000423	0.00149	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000414	0.00146	CcSEcCtD
Cefotetan—Nausea—Docetaxel—pancreatic cancer	0.000402	0.00142	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000373	0.00132	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—pancreatic cancer	0.000363	0.00128	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—pancreatic cancer	0.000361	0.00127	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—pancreatic cancer	0.000361	0.00127	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000345	0.00122	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000336	0.00119	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—pancreatic cancer	0.000336	0.00118	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—pancreatic cancer	0.000334	0.00118	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000334	0.00118	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—pancreatic cancer	0.000323	0.00114	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—pancreatic cancer	0.000312	0.0011	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000311	0.0011	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—pancreatic cancer	0.000299	0.00105	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—pancreatic cancer	0.00029	0.00102	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000289	0.00102	CcSEcCtD
Cefotetan—Rash—Epirubicin—pancreatic cancer	0.000288	0.00102	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—pancreatic cancer	0.000288	0.00101	CcSEcCtD
Cefotetan—Nausea—Epirubicin—pancreatic cancer	0.000271	0.000956	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—pancreatic cancer	0.000269	0.000947	CcSEcCtD
Cefotetan—Rash—Doxorubicin—pancreatic cancer	0.000266	0.000939	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—pancreatic cancer	0.000266	0.000939	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—pancreatic cancer	0.000251	0.000885	CcSEcCtD
